Notably Off Key: Questioning the Clinical Benefit of Perioperative Immunotherapy for Resectable Head and Neck Squamous Cell Carcinoma After KEYNOTE-689
M
Musaddiq Awan
(Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI)
J
James Caudell
(Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL)
S
Stuart Wong
(Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI)
B
Baran Sumer
(Department of Otolaryngology, University of Texas Southwestern Medical Center, Dallas, TX)
K
Kedar Kirtane
J
Joseph Zenga
D
David Sher
(Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 21
Published
July 20, 2026
Pages
1971-1973
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (7)
M
Musaddiq Awan
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
J
James Caudell
Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL
S
Stuart Wong
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
B
Baran Sumer
Department of Otolaryngology, University of Texas Southwestern Medical Center, Dallas, TX
K
Kedar Kirtane
J
Joseph Zenga
D
David Sher
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001